These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7854391)

  • 21. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
    Heather Watts D; Mofenson LM
    J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
    [No Abstract]   [Full Text] [Related]  

  • 22. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Graham SM
    Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
    [No Abstract]   [Full Text] [Related]  

  • 23. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV infections in children.
    Walker AR
    Emerg Med Clin North Am; 1995 Feb; 13(1):147-62. PubMed ID: 7851314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Possibilities of chemoprophylaxis and chemotherapy in protozoan opportunistic infections].
    Ortona L; Antinori A
    G Ital Chemioter; 1991; 38(1-3):83-5. PubMed ID: 1365619
    [No Abstract]   [Full Text] [Related]  

  • 26. Can I stop my PCP prophylaxis?
    Gaylord G
    Posit Living; 1999 Mar; 8(2):22. PubMed ID: 12492001
    [No Abstract]   [Full Text] [Related]  

  • 27. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
    Dworkin MS; Williamson J; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protect yourself from Pneumocystis carinii.
    AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus on use of co-trimoxazole.
    Trop Doct; 2001 Jul; 31(3):189-90. PubMed ID: 11444358
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary prophylaxis against opportunistic infections in patients with AIDS.
    Clumeck N
    N Engl J Med; 1995 Mar; 332(11):739-40. PubMed ID: 7854383
    [No Abstract]   [Full Text] [Related]  

  • 31. Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance.
    Hamer DH; Gill CJ
    Am J Trop Med Hyg; 2008 Sep; 79(3):299-300. PubMed ID: 18784218
    [No Abstract]   [Full Text] [Related]  

  • 32. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Gill CJ; Sabin LL; Tham J; Hamer DH
    Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
    Popa LG; Popa MI; Zaharia A; Ocneanu M
    Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethoprim-sulphamethoxazole rechallenge in 20 previously allergic HIV-infected patients after homeopathic.
    Bissuel F; Cotte L; Crapanne JB; Rougier P; Schlienger I; Trepo C
    AIDS; 1995 Apr; 9(4):407-8. PubMed ID: 7794554
    [No Abstract]   [Full Text] [Related]  

  • 37. Polypharmacy: dangers of multiple-drug therapy in patients with immunodeficiency virus infection.
    Ungvarski P; Schmidt J
    Home Healthc Nurse; 1993; 11(2):68-9. PubMed ID: 8478201
    [No Abstract]   [Full Text] [Related]  

  • 38. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
    Jacobson MA; French M
    AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both?
    Hudson CP; Roach TC
    Int J STD AIDS; 2003 Sep; 14(9):644-5. PubMed ID: 14511507
    [No Abstract]   [Full Text] [Related]  

  • 40. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
    Bikaako-Kajura W; Luyirika E; Purcell DW; Downing J; Kaharuza F; Mermin J; Malamba S; Bunnell R
    AIDS Behav; 2006 Jul; 10(4 Suppl):S85-93. PubMed ID: 16791525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.